OncWeekly Content Page - Page 17

Other Cancers

Ixazomib Transition in Multiple Myeloma: Subgroup Analysis From US MM-6

Dec 04, 2023

Other Cancers

Ide-Cel vs Standard Regimens in TCE RRMM

Dec 04, 2023

Other Cancers

Analysis of Factors Affecting Forimtamig Efficacy in RRMM Patients

Dec 01, 2023

Other Cancers

Genomic Profiling of HR SMM Patients in the GEM-CESAR Study

Dec 01, 2023

Advertisement

Other Cancers

Dostarlimab Combo in Endometrial Cancer: Cost Analysis of Grade ≥3 AEs

Nov 30, 2023

Other Cancers

NK Cell Expansion Pattern Link to Nemvaleukin Alfa Treatment Response

Nov 29, 2023

Other Cancers

Daratumumab-Based Tandem Transplant for High-Risk Myeloma

Nov 29, 2023

Other Cancers

Updated Boston Trial Results: Selinexor, Bortezomib, and Dexamethasone for Previously Treated Multiple Myeloma

Nov 28, 2023

Previous
1
…
15
16
17
18
19
…
66
Next

Sign up for our emails

Trusted insights straight to your inbox and get the latest updates from OncWeekly

Newsletter

Advertisement